Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Parkinson's Disease: Treatment01:24

Parkinson's Disease: Treatment

Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of its...
Alzheimer's Disease: Treatment01:22

Alzheimer's Disease: Treatment

Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
Pharmaceutical Poisoning: Treatment Strategies01:26

Pharmaceutical Poisoning: Treatment Strategies

Treatment strategies for poisoning are a critical aspect of emergency medicine, focusing on preventing the absorption of toxins and enhancing their elimination. When a poisoning incident occurs, the first response is to halt exposure and decontaminate the patient, particularly through gastrointestinal (GI) methods if the poison was ingested.Gastrointestinal Decontamination Techniques:Activated charcoal is the cornerstone of GI decontamination. It works through adsorption, binding the toxin to...
Rocky Mountain Spotted Fever01:26

Rocky Mountain Spotted Fever

Rocky Mountain Spotted Fever (RMSF) is a severe tick-borne illness caused by Rickettsia rickettsii, a Gram-negative, coccobacillary bacterium. This pathogen is an obligate intracellular parasite, requiring a host cell for replication. Transmission occurs through the bite of an infected tick. In the United States, the most important vectors are Dermacentor variabilis (American dog tick) and Dermacentor andersoni (Rocky Mountain wood tick), though other tick species may also serve as vectors.
Rabies01:28

Rabies

Rabies is a lethal zoonotic disease caused by a single-stranded, negative-sense RNA virus of the Lyssavirus genus, within the family Rhabdoviridae. Its primary mode of transmission to humans is through bites or saliva-contaminated scratches from infected mammals such as dogs, bats, raccoons, or foxes. Transmission can also occur if infectious saliva contacts abraded skin or intact mucous membranes, including the conjunctiva.Viral Entry and Early ReplicationOnce introduced at the bite or scratch...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Geospatial Tracking of a Rabies Outbreak in the Eastern Cape Province, South Africa, Using Molecular Data.

Transboundary and emerging diseases·2026
Same author

Frequency and persistence of post-acute symptoms after chikungunya, dengue, Zika and malaria in travellers: a prospective multi-centre study.

Journal of travel medicine·2026
Same author

Analysing outbreak signals, 2013-2024: The amsterdam UMC centre for Tropical Medicine and Travel Medicine Epi Alert programme - an observational study.

New microbes and new infections·2026
Same author

Rabies virus infection and immune activation in human epidermal keratinocytes: Implications for rabies transmission.

The Journal of investigative dermatology·2026
Same author

Detection of rabies virus RNA in dog-bite wounds in a rabies-endemic area: evidence from an observational cohort study.

EBioMedicine·2026
Same author

Preservation of adaptive immunity after nonmyeloablative hematopoietic cell transplantation in adults with sickle cell disease (PROTECT study).

Haematologica·2026

Related Experiment Video

Updated: Jun 27, 2026

Rabies Necropsy Techniques in Large and Small Animals
06:56

Rabies Necropsy Techniques in Large and Small Animals

Published on: July 30, 2019

11.7K

Rabies in humans: A treatment approach.

Cornelis A De Pijper1, Pieter P A M van Thiel1, Diederik van de Beek2

  • 1Centre for Tropical Medicine and Travel Medicine, Department of Infectious Diseases, Amsterdam Infection & Immunity, Amsterdam Public Health, Amsterdam University Medical Centres, University of Amsterdam, Amsterdam, the Netherlands.

Travel Medicine and Infectious Disease
|February 8, 2025
PubMed
Summary

Few rabies survivors exist, often with severe neurological issues. Experimental treatments, including monoclonal antibodies, were unsuccessful in two patients lacking key survival factors like high antibody titers, suggesting palliative care may be most rational.

Keywords:
LyssavirusMilwaukee protocolRabiesRabies virusTreatment

More Related Videos

Field Postmortem Rabies Rapid Immunochromatographic Diagnostic Test for Resource-Limited Settings with Further Molecular Applications
07:40

Field Postmortem Rabies Rapid Immunochromatographic Diagnostic Test for Resource-Limited Settings with Further Molecular Applications

Published on: June 29, 2020

13.3K
A Trap-Vaccinate-Release Protocol for Immunization of Skunks and Additional Rabies Vectors Against Rabies
04:10

A Trap-Vaccinate-Release Protocol for Immunization of Skunks and Additional Rabies Vectors Against Rabies

Published on: November 29, 2024

782

Related Experiment Videos

Last Updated: Jun 27, 2026

Rabies Necropsy Techniques in Large and Small Animals
06:56

Rabies Necropsy Techniques in Large and Small Animals

Published on: July 30, 2019

11.7K
Field Postmortem Rabies Rapid Immunochromatographic Diagnostic Test for Resource-Limited Settings with Further Molecular Applications
07:40

Field Postmortem Rabies Rapid Immunochromatographic Diagnostic Test for Resource-Limited Settings with Further Molecular Applications

Published on: June 29, 2020

13.3K
A Trap-Vaccinate-Release Protocol for Immunization of Skunks and Additional Rabies Vectors Against Rabies
04:10

A Trap-Vaccinate-Release Protocol for Immunization of Skunks and Additional Rabies Vectors Against Rabies

Published on: November 29, 2024

782

Area of Science:

  • Neurology
  • Infectious Diseases
  • Immunology

Background:

  • Rabies survivors are rare, frequently experiencing severe neurological deficits.
  • Established treatment protocols for rabies have limited success.
  • Experimental therapies may offer benefits if prognostic survival factors are present.

Purpose of the Study:

  • To describe the clinical course and treatment decisions for two rabies patients.
  • To compare the observed outcomes with published data on rabies treatment and survival factors.
  • To evaluate the efficacy of experimental treatments in the context of clinical practice.

Main Methods:

  • Detailed case reports of two patients with clinical rabies.
  • Comparison of clinical data with existing literature on rabies treatment and prognostic factors.
  • Analysis of treatment strategies, including supportive care and novel antibody-based therapies.

Main Results:

  • Neither patient presented with high serum or cerebrospinal fluid (CSF) antibody titers, a key survival factor.
  • Experimental treatment with intrathecal and intravenous monoclonal rabies antibodies was unsuccessful.
  • The antibody treatments minimally increased serum and CSF antibody levels.

Conclusions:

  • Higher-dose monoclonal antibody treatments administered systemically might be necessary for efficacy.
  • Experimental treatments are most promising in patients with favorable prognostic factors.
  • In the absence of survival factors, palliative care remains the most rational approach.